A detailed history of Virtu Financial LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 86,385 shares of VTYX stock, worth $131,305. This represents 0.01% of its overall portfolio holdings.

Number of Shares
86,385
Holding current value
$131,305
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$1.72 - $3.12 $148,582 - $269,521
86,385 New
86,385 $189,000
Q1 2023

May 01, 2023

BUY
$29.51 - $46.65 $379,439 - $599,825
12,858 New
12,858 $431,000

Others Institutions Holding VTYX

About Ventyx Biosciences, Inc.


  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $85.9M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.